During the past decade, Nanjing Drum Tower Hospital conducted 255 clinical trials. In the 10-year time frame, 255 clinical trials started and 21 clinical trials were completed, i.e. on average, 8.2% percent of trials that started reached the finish line to date. In the past 5 years, 171 clinical trials started and 21 clinical trials were completed. i.e. 12.3% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Nanjing Drum Tower Hospital" #1 sponsor was "The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School" with 44 trials, followed by "Janssen Research & Development, LLC" with 17 trials sponsored, "Eli Lilly and Company" with 15 trials sponsored, "Hoffmann-La Roche" with 13 trials sponsored and "Chinese Medical Association" with 13 trials sponsored. Other sponsors include 189 different institutions and companies that sponsored additional 122 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Nanjing Drum Tower Hospital" #1 collaborator was "The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School" with 19 trials as a collaborator, "The First Affiliated Hospital of Zhengzhou University" with 5 trials as a collaborator, "Eli Lilly and Company" with 3 trials as a collaborator, "First Affiliated Hospital Xi'an Jiaotong University" with 3 trials as a collaborator and "Gilead Sciences" with 3 trials as a collaborator. Other collaborators include 191 different institutions and companies that were collaborators in the rest 169 trials.

According to Clinical.Site data, the most researched conditions in "Nanjing Drum Tower Hospital" are "Erectile Dysfunction" (6 trials), "Multiple Myeloma" (6 trials), "Type 2 Diabetes Mellitus" (6 trials), "Ulcerative Colitis" (6 trials) and "Diabetes Mellitus, Type 2" (5 trials). Many other conditions were trialed in "Nanjing Drum Tower Hospital" in a lesser frequency.

Most popular intervention types in "Nanjing Drum Tower Hospital" are "Drug" (189 trials), "Device" (33 trials), "Biological" (29 trials), "Procedure" (29 trials) and "Other" (26 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (51 trials), "Capecitabine" (7 trials), "Dexamethasone" (7 trials), "Oxaliplatin" (7 trials) and "Prednisone" (7 trials). Other intervention names were less common.

The vast majority of trials in "Nanjing Drum Tower Hospital" are 247 trials for "All" genders, 27 trials for "Male" genders and 19 trials for "Female" genders.

Currently, there are NaN active trials in "Nanjing Drum Tower Hospital". 9 are not yet recruiting, 94 are recruiting, 46 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 74 completed trials in Nanjing Drum Tower Hospital, 2 suspended trials, and 10 terminated clinical trials to date.

Out of the total trials that were conducted in Nanjing Drum Tower Hospital, 42 "Phase 1" clinical trials were conducted, 71 "Phase 2" clinical trials and 99 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 18 trials, and there were also 51 trials that are defined as “Not Applicable".